Tanner Health and Healthliant Ventures partner with Optellum to launch an artificial intelligence (AI) platform designed to detect lung cancer.

Man’s best friend may become cancer’s worst enemy.

Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before ...

Researchers identified a 14-protein blood signature that may predict lung cancer years early, potentially enabling earlier ...

At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to ...

New patent expands globally protected IP estate beyond blood into alternative biofluids, positioning the Company's clinical mass spectrometry platform against traditional genomic liquid biopsies.

A machine learning model developed by researchers at the Johns Hopkins Kimmel Cancer Center filters out the biological noise in liquid biopsy samples, helping clinicians better match therapies to ...

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...